SOUTH SAN FRANCISCO– Claritas Rx, a company specializing in patient journey analytics, announced Monday the launch of Access Analytics, a real-time intelligence platform designed to give biopharma companies greater visibility into brand performance and patient access.
The platform unifies fragmented data from specialty pharmacies, payers, and support hubs into intuitive dashboards that track key metrics such as enrollments, conversion rates, time-to-fill, and persistence. By reducing the reporting delays common with traditional methods, Access Analytics aims to help Market Access teams identify barriers earlier, optimize contracts and workflows, and improve both patient outcomes and financial performance.
“Without real-time insights, barriers to treatment go unnoticed, patients face delays, and brand performance suffers,” said Michael Fitzgibbons, CEO of Claritas Rx. “Access Analytics delivers real-time dashboards that allow teams to respond faster, drive measurable improvements in patient care, and generate significant financial value for organizations.”
Market Access teams often struggle with incomplete or delayed information, relying on manual processes and disparate tracking tools that make proactive decision-making and partner engagement difficult. Claritas Rx said its platform addresses these gaps by offering transparency across the treatment continuum, enabling faster responses to emerging needs and better evaluation of program effectiveness.
In addition to product availability, the company released a new thought leadership piece, “One Month to $241K: Real-Time Market Access Insights Deliver Measurable Gains,” showcasing how timely visibility into access data can yield substantial business and patient care benefits.
